| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/08/1993 | WO1993013092A1 Imidazolidinedione derivatives |
| 07/08/1993 | WO1993013083A1 Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| 07/08/1993 | WO1993013079A1 Antifolate quinazolines |
| 07/08/1993 | WO1993013075A1 1-(arylalkyl-aminoalkyl)imidazole derivatives, processes of preparation and use as therapeutical agents |
| 07/08/1993 | WO1993013074A1 Substituted imidazole derivatives and their preparation and use |
| 07/08/1993 | WO1993013073A1 Substituted tetrahydroisoquinolines and their use as therapeutic agents |
| 07/08/1993 | WO1993013069A1 Heterocycle-substituted benzylamine derivatives as antiretroviral compounds |
| 07/08/1993 | WO1993013068A1 Tricyclic compound and medicine containing the same |
| 07/08/1993 | WO1993013055A1 Amidino derivatives and their use as nitric oxide synthase inhibitors |
| 07/08/1993 | WO1993013052A1 α-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES |
| 07/08/1993 | WO1993012817A1 Therapeutic combinations useful in the treatment of gastroesophageal reflux disease |
| 07/08/1993 | WO1993012814A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | WO1993012812A1 A stabilized pharmaceutical formulation comprising growth hormone and histidine |
| 07/08/1993 | WO1993012811A1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine |
| 07/08/1993 | WO1993012808A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/08/1993 | WO1993012802A1 Biomedical water soluble hydrophilic polyurethane polymers and method of use thereof |
| 07/08/1993 | WO1993012801A1 Pharmaceutical composition for the treatment of wounds, scars and keloids |
| 07/08/1993 | WO1993012800A1 An acidic polycyclic ether useful as an anticoccidial agent and as a growth promotant |
| 07/08/1993 | WO1993012799A1 Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis |
| 07/08/1993 | WO1993012798A1 Obesity inhibitor |
| 07/08/1993 | WO1993012797A1 Pharmaceutical compositions containing natural progesterone having a high biological availability |
| 07/08/1993 | WO1993012796A1 Use of renin inhibitors for the treatment of glaucoma |
| 07/08/1993 | WO1993012794A1 Use of an animazoline derivative for the treatment of glaucoma |
| 07/08/1993 | WO1993012793A1 A therapeutic process for the treatment of the pathologies of type ii diabetes |
| 07/08/1993 | WO1993012792A1 Remedy for diseases related to serotonergic neuron system |
| 07/08/1993 | WO1993012791A1 Central cholecystokinin antagonists having pharmaceutical activity |
| 07/08/1993 | WO1993012790A1 Use of arylindole derivatives for the treatment of psychoses |
| 07/08/1993 | WO1993012789A1 Use of spiperone or spiperone derivatives as immunosuppressant agents |
| 07/08/1993 | WO1993012788A1 Pyridylguanidine compounds for treatment of erectile dysfunction |
| 07/08/1993 | WO1993012787A1 New pharmaceutical compositions inhibiting gastric acid secretion and exerting gastrocytoprotective effect |
| 07/08/1993 | WO1993012786A1 Indolinone derivatives |
| 07/08/1993 | WO1993012785A1 Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases |
| 07/08/1993 | WO1993012784A1 Pharmaceutical preparations containing bilobalid for the treatment of nervous tension and anxiety |
| 07/08/1993 | WO1993012783A1 Oleaginous ointment |
| 07/08/1993 | WO1993012782A1 Method of treating viral diseases |
| 07/08/1993 | WO1993012781A2 Creatine analogs having antiviral activity |
| 07/08/1993 | WO1993012780A1 Potentiation of nmda antagonists |
| 07/08/1993 | WO1993012779A1 Compositions containing histamine-h2-receptor antagonists at low dosage |
| 07/08/1993 | WO1993012778A1 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 07/08/1993 | WO1993012777A1 Use of polyamines as ionic-channel regulating agents |
| 07/08/1993 | WO1993012776A1 Aids virus infection inhibitor composition |
| 07/08/1993 | WO1993012775A1 Pharmaceutical composition and process for the preparation thereof |
| 07/08/1993 | WO1993012774A1 Microemulsions for gallstone dissolution |
| 07/08/1993 | WO1993012773A1 Alleviating or prevention of migraine headache onset with mast cell degranulation blocking agents |
| 07/08/1993 | WO1993012765A1 A controlled release drug dispersion delivery device |
| 07/08/1993 | WO1993012764A1 Composition to help stop smoking |
| 07/08/1993 | WO1993012756A2 Transfection of lung via aerosolized transgene delivery |
| 07/08/1993 | WO1993012754A2 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 07/08/1993 | WO1993012657A1 Antiseptic |
| 07/08/1993 | WO1993012654A1 Medical uses of trioxolane and diperoxide compounds |
| 07/08/1993 | WO1992017077A3 Fat substitute compositions having reduced laxative effects |
| 07/08/1993 | CA2126976A1 Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| 07/08/1993 | CA2126757A1 Medical uses of trioxolane and diperoxide compounds |
| 07/08/1993 | CA2126686A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | CA2126678A1 Use of spiperone or spiperone derivatives as immunosuppressant agents |
| 07/08/1993 | CA2126571A1 Use of arylindole derivatives for the treatment of psychoses |
| 07/08/1993 | CA2126451A1 Compositions and methods for modulating .beta.-amyloid |
| 07/08/1993 | CA2126308A1 Therapeutic agents |
| 07/08/1993 | CA2126231A1 Compositions containing histamine-h2-receptor antagonists at low dosage |
| 07/08/1993 | CA2126211A1 Use of renin inhibitors for the treatment of glaucoma |
| 07/08/1993 | CA2126203A1 Inhibitors of 5-alpha-testosterone reductase |
| 07/08/1993 | CA2126177A1 Therapeutic agents |
| 07/08/1993 | CA2126108A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/08/1993 | CA2125858A1 Therapeutic agents |
| 07/08/1993 | CA2125856A1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine |
| 07/08/1993 | CA2125854A1 Imidazoquinazoline compounds and their preparation and use |
| 07/08/1993 | CA2125776A1 Pharmaceutical composition and process for the preparation thereof |
| 07/08/1993 | CA2125676A1 .alpha.-substituted benzenemethanamine derivatives |
| 07/08/1993 | CA2125675A1 Heterocycle-substituted benzenemethanamine derivatives |
| 07/08/1993 | CA2125568A1 Pharmaceutical composition for inhibiting the infection with aids virus |
| 07/08/1993 | CA2125563A1 Creatine analogs having antiviral activity |
| 07/08/1993 | CA2125392A1 Tertiary and secondary amines as alpha-2-antagonists and serotonin uptake inhibitors |
| 07/08/1993 | CA2124799A1 Potentiation of nmda antagonists |
| 07/08/1993 | CA2123312A1 A potent drug for treatment of erectile dysfunction |
| 07/08/1993 | CA2104477A1 Anti-proliferative and anti-inflammatory compounds: 5- 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- 6-position bound through the nitrogen atom |
| 07/07/1993 | EP0550385A1 Oral pharmaceutical compositions containing derivatives of methane-diphosphonic acid and 18-crown-6 ethers |
| 07/07/1993 | EP0550383A1 Medicament containing crystalline fumaric acid salts of 9,9-alkylen-3,7diazabicyclononane compounds |
| 07/07/1993 | EP0550337A1 Tissue protective tocopherol analogs |
| 07/07/1993 | EP0550292A1 Tissue protective tocopherol analogs |
| 07/07/1993 | EP0550157A1 Antitumor compositions and methods of treatment |
| 07/07/1993 | EP0550112A1 2-Saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and pharmaceutical compositions contaning them |
| 07/07/1993 | EP0550111A1 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them |
| 07/07/1993 | EP0550108A1 Sustained release thyroactive composition |
| 07/07/1993 | EP0550100A1 Sustained release suppositories and a process for preparation |
| 07/07/1993 | EP0550099A1 Oral hygiene compositions containing amino sugars as antiplaque agents |
| 07/07/1993 | EP0550083A1 Medicaments for treating imflammatory conditions or for analgesia containing a NSAID and canitidine bismuth citrate |
| 07/07/1993 | EP0550060A1 Cholesterol regulating material, cholesterol or body weight regulating composition, food, food material, beverage, and use of cholesterol regulating material |
| 07/07/1993 | EP0550008A2 Use of N-acyl derivatives of aminoalcohols with polycarboxylic acids for the manufacture of a medicament for the treatment of pathologies relating to mast cells |
| 07/07/1993 | EP0550006A2 Use of N-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells |
| 07/07/1993 | EP0549967A1 Polymers and oligomers of bile-acids, process for their production and their use as medicines |
| 07/07/1993 | EP0549927A2 Heterocyclic substituted carbamates and process for their preparation |
| 07/07/1993 | EP0549916A2 Compounds useful as antiproliferative agents |
| 07/07/1993 | EP0549880A1 N-(3-(2-(1H-imidazol-1-yl)ethoxy)phenyl)-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts |
| 07/07/1993 | EP0549879A2 Thiazol substituted quinolylmethoxyphenylacetic acid derivatives |
| 07/07/1993 | EP0549804A1 Acat inhibitor |
| 07/07/1993 | EP0549797A1 Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof |
| 07/07/1993 | EP0549794A1 Stock solution of sucralfate suspended in water and production thereof |
| 07/07/1993 | EP0549729A1 Antiviral compounds and antihypertensive compounds |
| 07/07/1993 | EP0549727A1 Carboxylic acid esters of rapamycin |
| 07/07/1993 | EP0549702A1 Uses of recombinant colony stimulating factor-1 |